The 2-Minute Rule for Atabecestat
All enrolled clients who acquired at the least one dose of zosuquidar or placebo all through induction were being monitored for your event of adverse events (439 sufferers, 219 on zosuquidar and 210 on placebo). The most typical adverse activities ended up related to the duration of extended and substantial myelosuppression as is expected with indu